The efficacy and safety of ondansetron in preventing postoperative nausea and vomiting following minor oral surgery was evaluated in a prospective randomized double-blind study. Of a total of seventy-seven patients, randomly 38 had 4 mg of ondansetron and 39 had normal saline as placebo intravenously immediately prior to induction of anaesthesia. A standard general anaesthetic with thiopentone, suxamethonium, fentanyl, nitrous oxide and isoflurane was employed. Postoperatively nausea was assessed verbally and on a visual analog scale at 1, 4 and 24 hours from the time of awakening. Episodes of vomiting were recorded. Eight patients (21.1%) in the ondansetron group compared to 19 (48.7%) in the placebo group had nausea (P< 0.05) and 1 (2.6%) in the ondansetron group compared with 9 (23.1%) in the placebo group vomited (P< 0.05). Patients who vomited twice or more and the number who required a rescue antiemetic were significantly fewer in the ondansetron group (P< 0.05). Cardiovascular parameters were stable and showed no significant difference in the two groups. There were no significant adverse effects that could be directly attributable to ondansetron.
Nausea and vomiting frequently occur in the postoperative period following general anaesthesia for minor oral surgery. This is mainly due to the blood ingested during and after surgery irritating the gastric mucosa and opioids used during and after anaesthesia stimulating the chemoreceptor trigger zone. Anaesthetic agents used such as nitrous oxide, isoflurane and enflurane may potentiate the above actions or may induce vomiting on their own. At present the antiemetic drugs commonly used are anticholinergics such as scopolamine, antihistamines such as prochlorperazine and promethazine, butyrophenones such as droperidol and dopamine antagonists such as metoclopramide. These may produce undesirable effects such as excessive sedation, dysphoria, hallucinations, hypotension or extrapyramidal symptoms.
Ondansetron is a 5-HT 3 receptor antagonist without any effect on dopamine, histamine, adrenergic or cholinergic receptor activityl. It has been effective and well tolerated as an antiemetic for emesis induced by cancer chemotherapy and radiation therapy2. It has been used successfully in patients undergoing gynaecologicaPS and laparoscopic procedures 6 . 8 under anaesthesia. However there are no reports of its use for prevention of postoperative nausea and vomiting following minor oral surgery. Thus it was decided to determine the efficacy of ondansetron as an antiemetic for prevention of postoperative nausea and vomiting following minor oral surgery by comparing it with placebo in a double-blind randomized study. The protocol and the proforma of consent were approved by the Ethical Committee of the Faculty of Dentistry of the University of Kong Kong.
MATERIALS AND METHODS
Following informed consent, eighty Hong Kong Chinese between the ages of 18 and 48 years, of ASA Grade I or II, scheduled to undergo minor oral surgery (r;:moval of impacted third molar teeth) which could not be carried out under local anaesthesia, were selected for the study provided male patients weighed less than 120 kg, female patients weighed less than 100 kg, and were not pregnant, breast-feeding or allergic to ondansetron.
Patients were premedicated with midazolam either 7.5 mg or 15 mg orally approximately one hour prior to induction. Monitoring of oxygen saturation, noninvasive blood pressure, ECG and heart rate were started prior to induction. The degree of nausea prior to surgery was noted on a visual analog scale (see below). With the use of a random allocation chart patients were selected either to receive ondansetron 4 mg in 2 ml, or saline 2 ml as placebo. The test drug was drawn up by the nursing officer of the operating theatre and was given by an anaesthetist, thus making it blind to patients, the anaesthetist and the surgeons. The test drug was administered intravenously immediately prior to induction of anaesthesia. The systolic and diastolic blood pressures and the pulse was recorded. Following preoxygenation anaesthesia was induced with fentanyl 25 to 50 p,g and thiopentone 4 to 5 mg/kg and the time of induction was noted. Suxamethonium 1.5 mg/kg was given for muscle paralysis. Following manual ventilation with 6 litres/ minute of 100070 oxygen and 1070 isoflurane, 4070 cocaine was sprayed into one of the nostrils using a Macintosh nasal spray. An endotracheal tube lubricated with water-based non-anaesthetic jelly was inserted via a nostril into the trachea either by direct laryngeal visualization or by using a fibreoptic bronchoscope. The patients were ventilated manually intermittently with 60 to 70070 N 2 0 in O 2 and 1 to 2070 isoflurane until they started to breathe spontaneously. The pharynx was gently packed using a damp ribbon gauze.
Following transfer to the theatre the patient was connected to a Lack system with a fresh gas flow of 60 to 70070 of N 2 0 in O 2 with 1 to 2070 isoflurane and allowed to breathe spo;ltaneously. Increments of fentanyl were administered as necessary up to a total of 100 p,g. The patient was positioned with a footdown tilt. Noninvasive blood pressure, ECG, oxygen saturation, pulse, and end tidal carbon dioxide were monitored.
At the end of the operation patients were positioned head-down, the pharynx was aspirated and the throat pack was removed. They were given 100070 oxygen and when breathing well were extubated.
In the recovery area patients received 30070 O 2 by mask and were nursed in a head-down position on the side. Oxygen saturation and noninvasive blood pressure were monitored. The time of first response to command was noted. Once the patients were awake and could maintain their airway they were transferred to the ward.
Nausea was charted on a visual analog scale 9 , one end of which indicated "no nausea" and the other end "severe nausea". It was recorded preoperatively and at 1, 4 and 24 hours from the time a patient first responded to command. These times were marked in the chart containing the visual analog scale. Nurses in the ward questioned the patients at these times and Anaesthesia and Intensive Care, Vo!. 22, No. 5, October. 1994 charted the degree of nausea up to that time. If the patients vomited, the time and the number of times they vomited were recorded.
If a patient vomited twice or more or if a patient requested an antiemetic, the nursing staff were instructed to give a rescue antiemetic, namely 6.25 mg of prochlorperazine intramuscularly. The time of administration of the rescue antiemetic was recorded by the nursing staff in the drug chart of the patient.
If the patients were in pain, they had an intramuscular injection of 0.1 mg/kg of morphine up to four hours from the time of cessation of anaesthesia and after four hours they were given 500 mg of paracetamol orally at minimum intervals of four hours.
After 24 hours from the time patients first responded to command, the surgeons questioned the patients to find out whether they had nausea and or vomiting during the postoperative period and noted the answers on the chart. The number of times a patient had vomited was copied from the nurses' chart.
At this time patients were questioned specifically whether they had any of the following: headache, musculoskeletal pain, abdominal pain, abdominal discomfort or cramps, constipation or pruritus. Any other symptoms were also noted.
The d).lration of anaesthesia was calculated as the duration from the time of induction to the time of cessation of anaesthesia. The time taken for recovery was calculated as the duration from the time of cessation of anaesthesia to the time the patients first responded to command. In calculating the nausea from the visual analog scale, 0 to 1 cm was considered as no nausea. Those who said they had nausea during the first 24 hours when being questioned at the end of the 24 hour period but had no nausea according to the visual analog scale were considered to have had nausea.
Statistical anaiysis of the results was done using Chisquare test for nonparametric data and two sample ttest for parametric data. The values were considered to be significant if P<0.05.
RESULTS
Eighty patients were included in the study. Of these results, three patients were eliminated as instead of paracetamol two had been given oral diflunisal and one Panadeine® (codeine and paracetamol) for relief of pain four hours after recovery. Of the 77 patients, 39 had normal saline and 38 had ondansetron prior to surgery. The demographic data does not show significant differences in the two treatment groups ( Table 1) .
Systolic and diastolic blood pressures and pulse rates did not reveal any clinically or statistically significant differences associated with the use of ondansetron. Four patients in the ondansetron group and 13 patients in the placebo group had nausea scores above 1 cm in the visual analog scale. Four patients in the ondansetron group and six patients in the placebo group had a nausea score of less than 1 cm in the visual analog score but said they had nausea during the assessment period. Eight patients in the ondansetron group had nausea compared with 19 in the placebo group (x' =6.47, P<0.05) ( Table 2 ). When the number of patients who had nausea up to 1, 4 and 24 hours from awakening was compared in the two groups the number who had nausea up to the fourth (X' =4.99, P<0.05) and 24th hour (x' =6.47, P<0.05) was significantly less in the ondansetron group (Figure 1) .
Similarly vomiting was significantly less in the ondansetron group (X' =7.1, P<0.05) and more patients vomited twice or more in the placebo group (X 2 = 4.11, P < 0.05). Six patients had the rescue antiemetic in the placebo group compared with none in the ondansetron group (x 2 =6.34, P<0.05).
The number who required analgesics in the first 24-hour postoperative period was not significantly different in the two groups ( Table 3) .
The common adverse effects were headache and musculoskeletal pain ( Table 4 ). The incidence of adverse effects was not significantly different in the two groups. Postoperative nausea and vomiting may occur due to a number of factors which may be related or unrelated to anaesthesia'o. Thus this study was controlled for several factors in order to reduce the influence of these factors on the results of the study. The factors that were controlled were the age, weight, type of surgery and site of surgery, the anaesthetic technique and the treatment of postoperative pain. There was no significant difference between groups in demographic data, dose of fentanyl used, duration of anaesthesia or the time for awakening. Nausea and vomiting in the first 24 hours was significantly less in the ondansetron group.
Number who required postoperative analgesics and had vomiting in the two treatment groups
Nausea and vomiting following oral surgery may be due to irritation of the gastric mucosa by the blood which passes into the stomach either during the operation or in the postoperative period. The afferents of this reflex may be vagal fibres containing 5-HT3 receptors". It may be the blocking of these afferents by ondansetron that significantly decreased the incidence of nausea and vomiting in our patients. Opioids either used during anaesthesia or for postoperative pain may have induced nausea or vomiting or both. Nitrous oxide and isoflurane may have potentiated or induced nausea and/or vomiting. Both opioids and anesthetic agents act on the chemoreceptor trigger zone in the area postrema. This area and parts of the nucleus of the tractus solitarius, adjacent sites in the brain, are known to be associated with nausea and vomiting. In animals these areas contain large numbers of 5-HT3 receptorsl214. It may be that ondansetron acts at these receptors to decrease the incidence of nausea and vomiting induced centrally.
The incidence of vomiting in patients having oral and head and neck surgery has been reported to be between 21 to 631110 1 ". In our study in the placebo group the incidence was 23% which is within the reported range. The reason for the incidence of this study to be in the lower end of the range may be because these patients had minor oral surgery where the doses of opioids used during anaesthesia were small, exposure to anaesthesia was short and blood loss was minor. We used thiopentone for induction as it is the standard drug used for induction in our unit. However if propofol was used the incidence of nausea and vomiting may have been even lower.
Many agents have been used for prevention and treatment of nausea and vomiting in oral surgery with varying degrees of success l ". However all currently employed antiemetics have some undesirable sideeffects when used at recommended dosages. In our study the commonest side-effects reported following treatment with ondansetron were headache and musculoskeletal pain. However the incidence was not different from that following placebo. Further, Anaesthesia and Intensive Care, Vol. 22, No. 5, October, 1994 following both ondansetron and placebo, cardiovascular stability was present both during and after anaesthesia. Thus, as in many other studies"" there were no definite side-effects solely attributable to ondansetron.
The cost of ondansetron appears to be a drawback to its routine use. It is ten times more expensive than prochlorperazine and forty times more expensive than metoclopramide.
